AcelRx: Replacing Morphine With Department Of Defense Funding

By: via Benzinga
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is a micro-cap company focused on the development and commercialization of therapies for the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.